CanadaSarclisa single‑use vial (500 mg/25 mL), DIN 02498243, lot 5F028A distributed in Nova Scotia is affected; nine units from this lot from three locations are being recalled. The recall was issued because units of the affected lot may have been frozen during shipment; consult your healthcare provider for health concerns, contact Sanofi‑aventis Canada Inc. with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Companies: Sanofi-aventis Canada Inc., 1755 Steeles Ave. West, Toronto, ON M2R 3T4.
How to identify it
Brand: Sarclisa; Product Name: Sarclisa; Market Authorization: DIN 02498243; Dosage Form: Single-use vial; Strength: 500 mg/25 mL; Lot Number: 5F028A
The hazard
Units of the affected lot may have been frozen during shipping.
Only nine (9) units from the lot are being recalled from three (3) locations in Nova Scotia.
What to do
Only a limited number of units within the lot are affected by this recall. Do not assume your product is affected solely because the lot number appears in the table.
Consult your healthcare provider for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
Where it was sold
Nova Scotia
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)